Expert suggestion for osteoporosis management during the recent COVID-19 pandemic

Abstract

Osteoporosis is a chronic condition that reflects reduced bone strength and increased risk for fracture. As a chronic disease, osteoporosis generally requires sustained medical intervention to reduce the risks for bone loss, impaired bone integrity and fractures. The coronavirus disease 2019(COVID-19) pandemic has brought the unprecedented harmful effects on medical service,such as the cessation of osteoporosis therapies might be associated with an increased harm for bone health. The present expert suggestion provides recommendation for the management of osteoporotic patient during COVID-19, to help them safely return to routine clinical management.

Keywords

• |covid-19|osteoporosis|osteoporotic fracture|anti-osteoporosis medication